These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19307116)

  • 1. GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Taggart AK; Cheng K; Carballo-Jane E; Gerard Waters M; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2121-4. PubMed ID: 19307116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Holt TG; Wolff MS; Taggart AK; Cheng K; Carballo-Jane E; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4472-4. PubMed ID: 20615702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
    Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).
    Boatman PD; Schrader TO; Kasem M; Johnson BR; Skinner PJ; Jung JK; Xu J; Cherrier MC; Webb PJ; Semple G; Sage CR; Knudsen J; Chen R; Taggart AK; Carballo-Jane E; Richman JG
    Bioorg Med Chem Lett; 2010 May; 20(9):2797-800. PubMed ID: 20363624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
    Shen HC; Taggart AK; Wilsie LC; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4948-51. PubMed ID: 18752940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.
    Shen HC
    Expert Opin Ther Pat; 2009 Aug; 19(8):1149-55. PubMed ID: 19566484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.
    Semple G; Skinner PJ; Gharbaoui T; Shin YJ; Jung JK; Cherrier MC; Webb PJ; Tamura SY; Boatman PD; Sage CR; Schrader TO; Chen R; Colletti SL; Tata JR; Waters MG; Cheng K; Taggart AK; Cai TQ; Carballo-Jane E; Behan DP; Connolly DT; Richman JG
    J Med Chem; 2008 Aug; 51(16):5101-8. PubMed ID: 18665582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia.
    Schmidt D; Smenton A; Raghavan S; Carballo-Jane E; Lubell S; Ciecko T; Holt TG; Wolff M; Taggart A; Wilsie L; Krsmanovic M; Ren N; Blom D; Cheng K; McCann PE; Gerard Waters M; Tata J; Colletti S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4768-72. PubMed ID: 19592242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist lead identification for the high affinity niacin receptor GPR109a.
    Gharbaoui T; Skinner PJ; Shin YJ; Averbuj C; Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Cherrier MC; Webb PJ; Tamura SY; Zou N; Rodriguez N; Boatman PD; Sage CR; Lindstrom A; Xu J; Schrader TO; Smith BM; Chen R; Richman JG; Connolly DT; Colletti SL; Tata JR; Semple G
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4914-9. PubMed ID: 17588745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties.
    Imbriglio JE; DiRocco D; Bodner R; Raghavan S; Chen W; Marley D; Esser C; Holt TG; Wolff MS; Taggart AK; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2011 May; 21(9):2721-4. PubMed ID: 21185185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
    Deng Q; Frie JL; Marley DM; Beresis RT; Ren N; Cai TQ; Taggart AK; Cheng K; Carballo-Jane E; Wang J; Tong X; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4963-7. PubMed ID: 18760600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
    Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel patent publications on high-affinity nicotinic acid receptor agonists.
    Shen HC; Colletti SL
    Expert Opin Ther Pat; 2009 Jul; 19(7):957-67. PubMed ID: 19552512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
    van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A
    J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
    Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
    Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b.
    Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Dang HT; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6619-22. PubMed ID: 17931863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
    Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
    J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.